Medicus Pharma Ltd (NASDAQ:MDCX) Sees Large Decrease in Short Interest

Medicus Pharma Ltd (NASDAQ:MDCX) was the target of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 911,128 shares, a decrease of 12.7% from the February 12th total of 1,043,199 shares. Based on an average daily trading volume, of 511,599 shares, the days-to-cover ratio is currently 1.8 days. Currently, 4.0% of the company’s stock are short sold. Currently, 4.0% of the company’s stock are short sold. Based on an average daily trading volume, of 511,599 shares, the days-to-cover ratio is currently 1.8 days.

Analysts Set New Price Targets

Several research firms have recently commented on MDCX. Weiss Ratings restated a “sell (d-)” rating on shares of Medicus Pharma in a report on Monday, December 29th. D. Boral Capital reissued a “buy” rating and issued a $27.00 price target on shares of Medicus Pharma in a research report on Monday, March 9th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $23.50.

Institutional Trading of Medicus Pharma

Several institutional investors have recently made changes to their positions in the company. Armistice Capital LLC bought a new position in shares of Medicus Pharma during the fourth quarter valued at about $2,771,000. Yorkville Advisors Global LP bought a new stake in Medicus Pharma in the 3rd quarter worth about $532,000. Jane Street Group LLC purchased a new stake in Medicus Pharma in the 4th quarter valued at about $92,000. HRT Financial LP bought a new position in shares of Medicus Pharma during the 4th quarter worth approximately $42,000. Finally, Wilmington Savings Fund Society FSB boosted its stake in shares of Medicus Pharma by 100.0% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 51,244 shares of the company’s stock worth $78,000 after buying an additional 25,622 shares during the last quarter.

Medicus Pharma Trading Up 2.2%

Shares of NASDAQ:MDCX traded up $0.01 during mid-day trading on Wednesday, hitting $0.51. 1,390,866 shares of the company traded hands, compared to its average volume of 4,291,250. The stock has a 50-day moving average price of $1.13 and a two-hundred day moving average price of $1.79. Medicus Pharma has a 12-month low of $0.37 and a 12-month high of $8.94. The stock has a market cap of $13.00 million, a P/E ratio of -0.24 and a beta of -1.60.

About Medicus Pharma

Medicus Pharma, Inc, traded on the Nasdaq under the ticker MDCX, is a specialty pharmaceutical company focused on the development, acquisition and commercialization of prescription therapies. The company’s core business centers on oncology supportive care and critical care products, with its lead offering being Levoleucovorin injection, an FDA-approved agent designed to reduce toxicity and enhance efficacy of certain chemotherapeutic regimens in colorectal cancer.

Headquartered in the United States, Medicus Pharma has built its portfolio through strategic licensing and acquisition of sterile injectable and oral therapies.